Objectives. We sought to determine the incidence and independent prognostic value of increased serum levels of sensitive serologic markers in patients in whom a conventionally diagnosed acute myocardial infarction had been ruled out.
Objectives. We sought to determine the incidence and independent prognostic value of increased serum levels of sensitive serologic markers in patients in whom a conventionally diagnosed acute myocardial infarction had been ruled out.
Background. Increased serum levels of creatine kinase (CK) isoenzyme MB mass and cardiac troponin T in patients with unstable angina pectoris are associated with a poor prognosis.
Methods. We analyzed data from 196 consecutive patients with suspected acute myocardial infarction, which was later ruled out in 124. Increased serum levels of CK-MB mass, troponin T and myosin light chains were compared with clinical findings, ST-T wave abnormalities and presence of arrhythmias.
Results. Of the patients in the noninfarction group, 28% had serum CK-MB mass >6 pg/liter, 20% had troponin T >0.20 pg/liter, and 26% had myosin light chains >0.4 #g/liter (discrimination limits). The cardiac event rate (cardiac death, nonfatal acute myocardial infarction) within 28 months was significantly higher in patients in the noninfarction group with elevated marker levels (range 22% to 24%) than in patients with values below these discriminators (range 3% to 5%) but was not significantly different from that in patients with a definite diagnosis of acute myocardial infarction (29%). Further, significant predictors of cardiac events were previous myocardial infarction; myocardial infarction or angina pectoris, or both; previous congestive heart failure; ST-T wave abnormalities on admission; a transient ST-T wave shift on serial electrocardiograms (ECGs); recurrent chest pain; and occurrence of supraventricular or ventricular tachycardia, or both, during the 1st 48 h after admission. It was found that all three biochemical markers, in the main, convey independent prognostic information with respect to dinical findings and presence of arrhythmias but not ST-T wave abnormalities on admission or a transient ST-T wave shift on serial ECGs.
Conclusions. Increased serum levels of CK-MB mass, troponin T and myosin light chains all detect a subgroup of 25% of patients without acute myocardial infarction who have as poor a prognosis as that of patients with a definite diagnosis of acute myocardial infarction. All three biochemical markers provide similar important independent prognostic information with regard to clinical findings and arrhythmias but add no additional prognostic information once ECG ST-T wave changes are considered.
(JAm Coil Cardiol 1995;25:574-81)
The diagnosis of acute myocardial infarction is based on typical clinical history, electrocardiographic (ECG) changes and characteristic serial changes in plasma enzyme levels (1,2), in particular serum creatine kinase (CK) isoenzymes and lactate dehydrogenase isoenzyme (1) . However, in the late mid-1980s improved immunoassays were developed to measure the mass concentration of serum CK-MB rather than its catalytic activity, as well as new immunoassays to measure structural proteins of the heart (troponin T, troponin I and myosin light chains) (3) (4) (5) (6) (7) (8) (9) (10) . Serum CK-MB mass and troponin T have been the subject of particular investigation. These assays have proved useful not only in the conventional diagnosis of acute myocardial infarction, but also in the diagnosis of minor myocardial injury among patients in whom an acute myocardial infarction has been ruled out (3, 4, (11) (12) (13) (14) (15) . It has been shown (3, (12) (13) (14) (15) that in 26% to 35% of such patients, the prognosis is similar to that in patients with a definite diagnosis of acute myocardial infarction. However, to our knowledge no study to date has investigated whether increased serum levels of CK-MB mass, troponin T and myosin light chains are of independent prognostic value. We therefore attempted to determine whether increased serum levels of these biochemical markers add independent prognostic information to clinical findings, ST-T wave abnormalities and arrhythmias in patients with suspected acute myocardial infarction and to evaluate whether troponin T and myosin light chains are superior to or complement CK-MB mass in this respect.
Methods
Patients. Two hundred thirty-five patients with suspected acute myocardial infarction who were admitted consecutively to the coronary care unit were considered for inclusion in the study. Patients were not included if they had undergone resuscitation (n = 6), had a documented myocardial infarction within the previous fortnight (n = 1), were residing in another county (n = 3) or had fewer than two blood samples drawn (n = 16).
In the coronary care unit, routine diagnostic procedures were based on history, medical examination, serial standard 12-lead ECG and laboratory tests described later. Patients were classified as those with and without acute myocardial infarction on the basis of a diagnosis made within 48 h of admission.
Patients with acute myocardial infarction. Seventy-two patients had a definite acute myocardial infarction according to World Health Organization criteria (2): 1) typical chest pain; 2) unequivocal ECG changes, that is, a new pathologic Q wave or evolution of a current injury (ST segment elevation lasting >24 h, followed by T wave inversion); and 3) characteristic increase in serum enzyme levels. For this study we used the following discrimination limits: serum CK >200 U/liter in men or 150 U/liter in women; serum CK-MB activity >24 U/liter and serum lactate dehydrogenase isoenzyme 1 >170 U/liter (blood sampling procedures and analytic methods are described later) (16, 17) .
Patients without acute myocardial infarction. In 137 patients who did not meet the previous criteria, acute myocardial infarction was ruled out. Reasons for admission were chest pain (n = 117), pulmonary edema (n = 9), tachyarrhythmias (n = 6) and fainting (n = 5). Of the 117 patients with chest pain, 72 (62%) had unstable angina that could be categorized according to the Braunwald (18) classification of unstable angina: class 1 = severe or accelerated angina of new onset (n = 2); class 2 = subacute angina at rest (i.e., not active within the previous 48 h) (n = 0); and class 3 = angina at rest within the previous 48 h (n = 70). Of the remaining 45 patients, 21 performed a bicycle exercise test with no sign of ischemia (the bicycle exercise test was carried out until exhaustion; no patient developed chest pain; median maximal work load was 160 W, range 90 to 240; no signs of isehemia appeared on the ECG [i.e., ->0.1-mV ST segment depression 0.08 s after the J point]), and an exercise test was inconclusive or could not be carried out because of administrative or physical reasons in 11 patients. An obvious nonischemic etiology of chest pain was established in the remaining 13 patients, who were omitted from further analysis: pericarditis or endocarditis (n = 4), pneumonia (n = 2), pulmonary cancer (n = 1), cholecystitis (n = 1), gastritis (n = 1), hyperventilation (n = 1), thyreotoxicosis (n = 1), Marfan syndrome (n = 1) and fibromyalgia (n = 1). Thus, the study included 72 patients with and 124 without acute myocardial infarction. Patients readmitted during the follow-up period were included on their first admission only.
Electrocardiography, Electrocardiography was performed on admission and thereafter at least once daily for all patients. The following definitions were used: ST-T wave abnormalities = ST segment deviation (ST segment depression ->0.1 mV or elevation ->0.1 mV in limb leads or 0.2 mV in precordial leads) or Y wave inversion, or both, on the ECG; uncodable ECG = poor quality or the presence of suppression codes (i.e., bundle branch block, artificial pacemaker, complete atrioventricular block). We further classified the patients according to the daily ECG recordings as those having a transient ST-T wave shift or no or nonprogressive ST-T wave abnormalities.
The ECGs were evaluated independently by two of the investigators (J.R., H.N.) who had no knowledge of the biochemical marker results. A consensus was reached in cases of discrepancy.
Blood sampling. Blood sampling was performed according to a programmed time schedule (19) . Blood samples were collected three times daily (8 AM and 2 and 8 PM) for up to 48 h. The first sample was drawn at the first of these fixed times after admission. The samples were drawn into tubes without an anticoagulant agent. After coagulation, the samples were centrifuged at 3,000 g for 10 rain. The serum was stored at a minimal temperature of -80°C until analysis. After thawing, the serum was again centrifuged to remove any precipitate. The serum levels of CK and CK-MB activity were determined for all samples; lactate dehydrogenase isoenzyme i levels were determined for samples drawn at 8 AM. In the present study, serum levels of CK-MB mass, troponin T and myosin light chains were determined for all samples.
Analytic methods. Serum CK-MB mass concentrations were determined by an immunoenzymetric assay (NovoClone, DAKO, Denmark), which is based on a two-site immunometric sandwich method using two monoclonal antibodies (details have been reported elsewhere [9] ). The detection limit for CK-MB was 0.1 /xg/liter, and the intraassay coefficient of variation was 0.03 at a reference value of -6/xg/liter (9). The analysis used two different discriminator values based on the results of previous studies (8 and 6/~g/liter) (4, 9, 13, 14) .
Troponin T immunoassay [ELISA Troponin(e) T] was carried out using the Enzymun-Test System ES22 analyzer (Boehringer Mannheim GmbH, Mannheim, Germany), which is based on a single-step sandwich principle (20) , with streptavidin-coated tubes as the solid phase and two monoclonal antihuman cardiac troponin T antibodies (measuring range 0.00 to 15/zg/liter) (4, 20) . The intraassay coefficient of variation was 0.06 at -0.20 /zg/liter (15) , and the discriminator value used was 0.20 gg/liter (4, 12, 15) .
Human ventricular myosin light chain isotype 1 levels were measured by a newly developed immunoenzymetric assay (Novo-Nordisk Bioscience A/S, Copenhagen, Denmark) and is based on a two-site immunometric sandwich method with two monoclonal antibodies (7). The detection limit for myosin light chains is 0.4/zg/liter, which was also used as the discrimination limit because reference subjects do not have detectable amounts of myosin light chains in serum (99% percentile in 190 reference subjects) (7) . The intraassay coefficient of variation was 0.13 at -1 tzg/liter.
Catalytic activity levels of serum CK, CK-B and lactate dehydrogenase isoenzyme 1 were determined at 37°C on a Cobas Bio (Hoffmann-La Roche, Basel, Switzerland). Serum CK levels were determined by the method of the Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology (reference range in normal subjects -<200 U/liter in men, -<150 U/liter in women) (16, 21) , and serum CK-B activity was determined after immunoinhibition of the M subunit, both using reagents from Boehringer Mannhelm. The CK-B results were multiplied by 2 to be expressed as serum CK-MB (discriminator value -<24 U/liter) (16, 17) . Because the reference range for CK-MB activity is <12 U/liter, we also analyzed the data using 18 and 12 U/liter as discriminator values (17) . Serum lactate dehydrogenase isoenzyme 1 levels were determined using the immunoprecipitation method (Hoffmann-La Roche) (discriminator value -<170 U/liter) (19) .
Follow-up. The patients were followed up for 28 months after admission to record cardiac events (nonfatal acute myocardial infarction or cardiac death [fatal acute myocardial infarction, sudden cardiac death or other cardiac death]). Information was obtained from the hospital records of the local county central registry, which contains complete information on all hospital admissions in the county. Admission to hospital for suspected acute myocardial infarction is routine. No patients were lost to follow-up. At the end of the study, 39 of the 196 patients had died (cardiac deaths, n = 29; noncardiac deaths, n = 10). Death certificates were available for all patients and autopsy reports for 15 (38%) of 39. A total of 382 patient-years at risk had been accumulated (mean 2.0, range 3 days to 2.3 years).
Statistics. Between-group comparisons were performed using the Fisher exact test. The Mann-Whitney U test was used for comparisons of age. The Kaplan-Meier method and a log-rank test were used for univariate analysis of time to cardiac events (see earlier). Noncardiac death was treated as a censored observation. Exact logistic regression analysis was used to estimate the independent prognostic value of biochemical markers compared with clinical and ECG findings in bivariate statistical analysis. All tests were computerized using Bio Medical Data Packing statistical software and Statistical Software for Exact Nonparametric Inference (22, 23) ; p = 0.05 was considered significant.
Results
Medical history and clinical outcome. More patients with acute myocardial infarction ruled out had a history of angina pectoris (p = 0.02), previous myocardial infarction (p = 0.03), coronary angiography (p = 0.008) and coronary artery bypass graft surgery or percutancous transluminal coronary anglo- plasty (p = 0.002) than patients with acute myocardial infarction. Patients with acute myocardial infarction were somewhat older than those without acute myocardial infarction (p = 0.007); otherwise, the groups were similar ( Table 1) .
The follow-up period included hospital stay and the period after discharge. In hospital, the mortality rate was 11% (8 of 72) in patients with acute myocardial infarction and 1.6% (2 of 124) in patients without acute myocardial infarction. The percent of patients with cardiac events was higher in those with than without acute myocardial infarction (log-rank test, p = 0.0001) ( Table 1 , Fig. 1 ) and was 25% and 6% after 1 year, respectively. Coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty was later performed in 8% of patients with and 6% of patients without acute myocardial infarction. None of the patients without acute myocardial infarction who had a later cardiac event underwent either of these procedures during the follow-up period.
Biochemical subgrouping of patients without acute myocardial infarction. Maximal values from the serial sampling performed within 48 h after admission in patients with and without acute myocardial infarction and those without acute myocardial infarction subgrouped according to serum CK-MB mass Table 2 . Of the patients without acute myocardial infarction, all three markers were below their respective discrimination limits in 59%; one marker was elevated in 20%, two markers in 9%, and all three markers in 12%. There was no difference in medical treatment (nitroglycerin, beta-adrenergic blocking agents, calcium channel blocking agents, angiotensin-converting enzyme inhibitors, acetylsalicylic acid or other anticoagulant agents) between the subgroups of patients without acute myocardial infarction who had increased versus decreased serum troponin T values or increased versus decreased myosin light chain values on admission or at discharge. Patients with increased serum CK-MB mass concentration had similar results, but more patients with decreased CK-MB mass values were discharged with calciumblocker therapy.
Among the eight patients without acute myocardial infarction who underwent coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty during the follow-up period, one had elevated serum CK-MB mass, troponin T and myosin light chain levels, one had elevated serum troponin T, and two had elevated serum myosin light chain levels.
Univariate analysis for patients without acute myocardial infarction (log-rank test). Patients without acute myocardial
infarction were subgrouped according to clinical findings, ST-T wave abnormalities on admission, a transient ST-T wave shift and presence of arrhythmias and biochemical marker levels during the 1st 48 h after admission (Table 3) . Data for patients who had a cardiac event are displayed in Table 4 .
Independent prognostic value for patients without acute myocardial infarction (exact logistic regression analysis).
Serum CK-MB mass ->6 /zg/liter, troponin T ->0.20 /~g/liter and myosin light chains ->0.4 ~g/liter add, in the main, independent prognostic information with regard to all clinical findings and arrhythmias found significant in the univariate analyses but not ST-T wave abnormalities on admission or a transient ST-T wave shift in serial ECGs (Table 5) . Estimated odds ratios between cardiac events and clinical or ECG findings, adjusted for biochemical marker serum levels, were calculated in a manner similar to those in Table 5 . Knowledge of previous myocardial infarction; myocardial infarction or angina pectoris, or both, showed independent prognostic information with respect to biochemical markers but not for other clinical findings, ST-T wave abnormalities on admission, a transient ST-T wave shift in serial ECGs or arrhythmias.
Discussion
The key question is whether increased serum levels of CK-MB mass, troponin T and myosin light chains are of independent prognostic value in patients in whom an acute myocardial infarction is ruled out. We studied these variables in all patients with a suspected acute myocardial infarction who were admitted to the coronary care unit, including those with a definite diagnosis of acute myocardial infarction who were included in the study as a reference group for prognosis. We found a 1-year cardiac event rate of 25% for patients with and 6% for those without acute myocardial infarction (p = 0.0001), Table 2 similar to previous observations (13, (24) (25) (26) . A history of angina pectoris or previous myocardial infarction as well as a slightly younger age were more frequent among patients without than with acute myocardial infarction. Thus, our findings in patients without acute myocardial infarction correspond well to those of other studies (15, 26) .
Biochemical subgrouping and clinical outcome. Patients without acute myocardial infarction were subgrouped according to various discriminator values chosen from previous studies of CK-MB mass, troponin T and myosin light chains (4, 9, (12) (13) (14) (15) . Those patients without acute myocardial infarction who had maximal serum CK-MB mass ->6 /tg/liter, troponin T ->0.20 ~g/liter or myosin light chains ->0.4/xg/liter had a cardiac event risk rate of 22% to 24%, significantly higher than the 3% to 5% rate in patients with values below the discrimination limits but not different from risk rates in patients with acute myocardial infarction (Fig. 1, bottom) . However, neither unspecific elevation of CK levels nor fluctuations of CK levels within the normal reference range nor CK-MB activity with even lower discrimination limits offers prognostic information with respect to patients without acute myocardial infarction. A poor signal-to-noise ratio, when lower discriminatory values of CK-MB activity measured by immunoinhibition are used, is probably why CK-MB activity is not able to detect patients with a poor prognosis. Thus, conventional enzyme levels are inferior to the new sensitive biochemical markers for detecting patients without acute myocardial infarction who have a poor prognosis. Because most patients without acute myocardial infarction who had CK-MB mass, troponin T, and myosin light chains values that were all either above or below the discrimination limits used, each of these biochemical markers is equally viable for use in prognosis. Beyond this, the choice of marker depends on the additional information required and local laboratory facilities (3) (4) (5) (6) (7) .
Predictors of clinical outcome. In accordance with other investigators (26, 27) , the clinical and ECG variables found significant for a poor prognosis were previous myocardial infarction; myocardial infarction or angina pectoris, or both; previous congestive heart failure; ST-T wave abnormalities on admission; a transient ST-T wave shift on serial ECGs; recur- PE -pulmonary edema: Pt = patient; UAP = unstable angina pectoris (Braunwald classification 1, 3) ; other abbreviations as in Tables 2 and 3 . Tables l to 3. rent chest pain; and occurrence of supraventricular or ventricular tachycardia, or both, during the 1st 48 h after admission. In addition to clinical conditions, CK-MB mass, troponin T and myosin light chains levels convey independent prognostic information. However, only knowledge of previous myocardial infarction; myocardial infarction or angina pectoris, or both, added independent prognostic information with regard to biochemical markers. The finding that these sensitive biochemical markers do not add independent prognostic information with respect to ST-T wave abnormalities on admission or a transient ST-T wave shift on serial ECGs, or vice versa, points to the possibility that they reflect the same process in the myocardium. However, nondiagnostic ECG results are so common that the use of sensitive biochemical markers for diagnosis is advantageous (28) .
Minor myocardial injury and clinical outcome. The present investigation and other recent studies (3, (11) (12) (13) (14) imply that detection of minor myocardial injuries by sensitive biochemical markers is as important as diagnosing acute myocardial infarction by other means. The parallel cardiac event curves during the entire follow-up period for patients with acute myocardial infarction and those with elevated CK-MB mass, troponin T or myosin light chain levels illustrate the similarity of these patients. One might therefore consider this group to be part of the spectrum of patients with non-Q wave myocardial infarction, as proposed by earlier angiographic and clinical studies and because newer insight into the pathogenesis of the acute coronary syndromes has shown that minor myocardial cell necrosis occurs frequently in high risk patients (29, 30) . Most later cardiac events occurred in patients with unstable angina pectoris, and their identification could complement a risk stratification scheme for selection of patients for coronary angiography (27) . However, future prospective studies must determine whether patients so identified will benefit from more aggressive medical treatment (e.g., thrombolytic, anticoagulant, antithrombotic agents) or invasive revascularization procedures, or both.
Conclusions. Increased levels of serum CK-MB mass, troponin T and myosin light chains all detect a subgroup of patients in whom an acute myocardial infarction has been ruled out but with a prognosis as grave as that of patients with a definite diagnosis of acute myocardial infarction. All three biochemical markers convey similar important independent prognostic information with regard to clinical findings and arrhythmias but add no additional prognostic information once the ECG ST-T wave changes are considered.
